Castle Biosciences CSTL Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Castle Biosciences in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Castle Biosciences's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Castle Biosciences's financing cash flow?
- Castle Biosciences (CSTL) reported financing cash flow of -$5.03M in Q1 2026.
- How has Castle Biosciences's financing cash flow changed year-over-year?
- Castle Biosciences's financing cash flow decreased by 224.1% year-over-year, from -$1.55M to -$5.03M.
- What is the long-term trend for Castle Biosciences's financing cash flow?
- Over 2 years (2021 to 2025), Castle Biosciences's financing cash flow has grown at a 14.1% compound annual growth rate (CAGR), from $5.42M to -$7.06M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.